Brief: GH Research Announces Successful Outcome of the Phase 2 part of its Phase 1/2 Clinical Trial of GH001 in Treatment-Resistant Depression

GH Research

06/12/2021 13:01

Dec 6 (Reuters) - GH Research PLC  GHRS.O :
    * GH RESEARCH ANNOUNCES SUCCESSFUL OUTCOME OF THE PHASE 2
PART OF
ITS PHASE 1/2 CLINICAL TRIAL OF GH001 IN TREATMENT-RESISTANT
DEPRESSION
    * GH RESEARCH PLC - PRIMARY ENDPOINT MET IN PHASE 2 PART OF
CLINICAL TRIAL FOR GH001 IN TRD
    * GH RESEARCH PLC - GH001 WAS WELL TOLERATED AND NO SERIOUS
ADVERSE EVENTS WERE REPORTED

Source text for Eikon:  ID:nGNXqSQ6N 
Further company coverage:  GHRS.O 

 ((Reuters.Briefs@thomsonreuters.com;;))